CC
CANO

Clearline Capital’s Cano Health, Inc. CANO Stock Holding History

Clearline Capital’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,014
Closed -$1.75M – 154
2022
Q3 		$1.75M Hold
2,014
– – 0.21% 78
2022
Q2 		$882K Hold
2,014
– – 0.11% 93
2022
Q1 		$1.28M Buy
2,014
+150
+8% +$94.6K 0.15% 87
2021
Q4 		$1.66M Hold
1,864
– – 0.18% 79
2021
Q3 		$2.36M Buy
1,864
+984
+112% +$1.19M 0.22% 74
2021
Q2 		$1.06M Buy
880
+73
+9% +$98.5K 0.16% 88
2021
Q1 		$1.07M Buy
807
+648
+408% +$917K 0.14% 73
2020
Q4 		$213K Buy
+159
New +$182K 0.05% 69

Other funds holding CANO

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Clearline Capital's CANO Position: Q4 2022 in Review

Clearline Capital sold out of Cano Health, Inc. (CANO) in Q4 2022, closing a stake of 2,014 shares — an estimated $1.75M sold.

Clearline Capital first reported a position in CANO in Q4 2020 and held it in 8 quarters. The position peaked at $2.36M in Q3 2021. 186 funds tracked by Wall St. Rank hold CANO as of Q4 2022.

  • Clearline Capital reported no remaining Cano Health, Inc. position as of Q4 2022 after selling out during the quarter.
  • Clearline Capital sold 2,014 Cano Health, Inc. shares in Q4 2022, an estimated $1.75M.
  • Clearline Capital first reported a position in Cano Health, Inc. in Q4 2020 and held it in 8 quarters.
  • Clearline Capital's Cano Health, Inc. position peaked at $2.36M in Q3 2021.
  • 186 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2022.

Based on Clearline Capital's 13F filing for Q4 2022, filed 14 Feb 2023.